ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer.

Wanting Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.